Prostate cancer progression and mortality: a review of diet and lifestyle factors

World Journal of Urology

Volumn 35, Issue 6, 2017, Pages 867-874

  Peisch, Sam F ^a   Van Blarigan, Erin L ^b,c   Chan, June M ^b,c   Stampfer, Meir J ^a,d   Kenfield, Stacey A ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Diet; Lethal prostate cancer; Lifestyle; Prostate cancer progression

Indexed keywords

ADULT; AGED; ATTITUDE TO HEALTH; DISEASE EXACERBATION; EXERCISE; HEALTHY DIET; HUMAN; INCIDENCE; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL ANALYSIS;

ADULT; AGED; ATTITUDE TO HEALTH; DISEASE PROGRESSION; EXERCISE; HEALTHY DIET; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 84982165950     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-016-1914-3     Document Type: Article

References (60)

1. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591–1597
2. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9:1039–1047
3. Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4:486–501
4. Joshu CE, Mondul AM, Menke A, Meinhold C, Han M, Humphreys EB et al (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 4:544–551
5. Ploussard G, de la Taille A, Bayoud Y, Durand X, Terry S, Xylinas E et al (2012) The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance. Eur Urol 61:356–362
6. Bonn SE, Wiklund F, Sjolander A, Szulkin R, Stattin P, Holmberg E et al (2014) Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes Control 25:933–943
7. Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC et al (2013) Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. J Clin Oncol 31:3069–3075
8. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316
9. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29:726–732
10. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71:3889–3895
11. Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E et al (2015) Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomark Prev 24:57–64
12. Baumann FT, Zopf EM, Bloch W (2012) Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials. Support Care Cancer 20:221–233
13. Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW et al (2015) Physical activity and prostate tumor vessel morphology: data from the health professionals follow-up study. Cancer Prev Res (Phila) 8:962–967
14. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E (2011) Smoking and prostate cancer survival and recurrence. JAMA 305:2548–2555
15. Rieken M, Shariat SF, Kluth LA, Fajkovic H, Rink M, Karakiewicz PI et al (2015) Association of cigarette smoking and smoking cessation with biochemical recurrence of prostate cancer in patients treated with radical prostatectomy. Eur Urol 68:949–956
16. Xie B, He H (2012) No association between egg intake and prostate cancer risk: a meta-analysis. Asian Pac J Cancer Prev 13:4677–4681
17. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM (2011) Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila) 4:2110–2121
18. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM (2010) Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr 91:712–721
19. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC et al (2012) Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr 96:855–863
20. Johansson M, Van Guelpen B, Vollset SE, Hultdin J, Bergh A, Key T et al (2009) One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomark Prev 18:1538–1543
21. Szymanski KM, Wheeler DC, Mucci LA (2010) Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 92:1223–1233
22. Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM et al (2013) Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105:1132–1141
23. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ et al (2006) Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 17:199–208
24. Galet C, Gollapudi K, Stepanian S, Byrd JB, Henning SM, Grogan T et al (2014) Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy. Cancer Prev Res (Phila) 7:97–104
25. Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A et al (2009) Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol 170:1165–1177
26. Alexander DD, Mink PJ, Cushing CA, Sceurman B (2010) A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer. Nutr J 9:50
27. Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ et al (2011) Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103:876–884
28. Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL (2013) Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control 24:1947–1954
29. Discacciati A, Orsini N, Wolk A (2014) Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis. Ann Oncol 25:584–591
30. Higdon JV, Delage B, Williams DE, Dashwood RH (2007) Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55:224–236
31. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC et al (2007) Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 99:1200–1209
32. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR et al (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case–control study. Cancer Epidemiol Biomark Prev 9:795–804
33. Richman EL, Carroll PR, Chan JM (2012) Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer 131:201–210
34. Yan L, Spitznagel EL (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89:1155–1163
35. Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J et al (2013) Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA 310:170–178
36. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, JPHC Study Group (2008) Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167:71–77
37. Jian L, Lee AH, Binns CW (2007) Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 16(Suppl 1):453–457
38. Lin YW, Hu ZH, Wang X, Mao QQ, Qin J, Zheng XY et al (2014) Tea consumption and prostate cancer: an updated meta-analysis. World J Surg Oncol 12:38
39. Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D (2011) Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer 63:663–672
40. Brausi M, Rizzi F, Bettuzzi S (2008) Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol 54:472–473
41. Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D et al (2015) Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate 75:550–559
42. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ et al (2014) Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 106(2):djt430. doi:10.1093/jnci/djt430
43. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH et al (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59:1225–1230
44. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP et al (2007) Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev 16:962–968
45. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94:391–398
46. Haseen F, Cantwell MM, O’Sullivan JM, Murray LJ (2009) Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis 12:325–332
47. Ansari MS, Gupta NP (2003) A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 92:375–378 (discussion 8)
48. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F et al (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomark Prev 10:861–868
49. Aune D, Navarro Rosenblatt DA, Chan DS, Vieira AR, Vieira R, Greenwood DC et al (2015) Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr 101:87–117
50. Song Y, Chavarro JE, Cao Y, Qiu W, Mucci L, Sesso HD et al (2013) Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr 143:189–196
51. Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC et al (2012) Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomark Prev 21:428–436
52. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J (2007) A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomark Prev 16:1364–1370
53. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC et al (2003) A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomark Prev 12:64–67
54. Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT et al (2009) Circulating fatty acids and prostate cancer risk in a nested case–control study: the multiethnic cohort. Cancer Causes Control 20:211–223
55. Fradet Y, Meyer F, Bairati I, Shadmani R, Moore L (1999) Dietary fat and prostate cancer progression and survival. Eur Urol 35:388–391
56. Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, Wolk A et al (2012) Dietary fatty acid intake and prostate cancer survival in Orebro County, Sweden. Am J Epidemiol 176:240–252
57. Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC et al (2013) Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med 173:1318–1326
58. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J et al (2012) Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA 308:1871–1880
59. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM et al (2014) Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 106(3):djt456. doi:10.1093/jnci/djt456
60. Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, Giovannucci EL, Chan JM (2015) Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst 107:360